Allergan 4Q Revenues: $3.9 billion (+7%) 4Q Earnings: $1.2 billion (loss of $629.3 million 4Q15) FY Revenues: $14.6 billion (+15%) FY Earnings: $15.0 billion (earnings were $3.9 billion FY15) Comments: Growth in the quarter was driven by BOTOX Cosmetic, with $199.4 million in sales, up 18% reflecting continued volume growth, and BOTOX Therapeutic revenues of $313.5 million, up 14%. KYBELLA, which launched in August, had sales of $12 million in the quarter. LINZESS sales were $173....